News

UnitedHealth (NYSE: UNH) revised its annual targets, disappointing stock market investors.

*Stock prices used were the afternoon prices of July 28, 2025. The video was published on July 30, 2025.

Pfizer (NYSE: PFE) has been around for over 175 years, but it became a true household name during the COVID-19 pandemic as one of the main vaccine suppliers. That led to its stock price and revenue

Five years ago, the eyes of the world were on Pfizer (NYSE: PFE). The big drugmaker was racing to develop a COVID-19 vaccine with its partner, BioNTech (NASDAQ: BNTX). Its stock was poised for a

An old country song morbidly titled "Gloom, Despair, and Agony on Me" included the lyrics, "If it weren't for bad luck, I'd have no luck at all." This might be an apt motto for UnitedHealth Group

UnitedHealth Group (NYSE:UNH), a leading diversified healthcare and insurance provider, reported results for the second quarter of fiscal 2025 on July 29, 2025. The most significant news was its

For years UnitedHealth Group (NYSE: UNH) has normally been a reliable dividend stock. But an abysmal start to 2025 has wiped out many of the gains that investors have achieved in recent years, with

You'd think that companies with long, successful track records and market caps in the hundreds of billions of dollars would be viewed as relatively formidable. However, that's not always the case.

In this video, I will talk about UnitedHealth Group (NYSE: UNH) and why buying the stock before it reports earnings could make sense. Watch the short video to learn more, consider subscribing, and

A stock market that keeps reaching all-time highs hardly seems like anything for investors to complain about. But if you're trying to build a growing stream of passive income, extended bull markets

It's been an awful, horrible, lousy year so far for UnitedHealth Group (NYSE: UNH). If I opened a thesaurus, I could easily find plenty of other apt descriptions for the healthcare giant's

Pharmaceutical giants Pfizer (NYSE: PFE) and Novo Nordisk (NYSE: NVO) have lagged the market over the past year, although Pfizer's poor performance dates back much further. Though these companies

One of the big reasons to like Pfizer (NYSE: PFE) today is its huge 7.1% dividend yield. To put that yield into context, the S&P 500 index is yielding roughly 1.3% and the average healthcare stock a

If putting your money to work on Wall Street is something you haven't started doing because it feels like a rich person's game and you're not one, I've got good news. Discount brokerages no longer

After briefly dipping into bear market territory just three months ago, the S&P 500 (SNPINDEX: ^GSPC) has quickly managed to recover, rising 6.6% year to date (as of this writing). But not all

Ayrshire Capital Management LLC sold its position in UnitedHealth Group Incorporated(NYSE:UNH) during the quarter ended June 30, 2025, executing trades totaling $5.98 million.

According to a recent

A few years ago, Pfizer (NYSE: PFE) was on top of the world when it came to earnings and stock price performance. The pharma giant recorded a record of $100 billion in sales back in 2022, and saw

According to a SEC filing dated July 10, Ferguson Wellman Capital Management sold 155,436 shares of UnitedHealth Group(NYSE:UNH) during the quarter ending June 30, 2025, with transactions totaling

UnitedHealth Group (NYSE: UNH) faces a series of unprecedented challenges, from leadership crises to federal investigations, leading to a significant stock decline. Is this the end of its dominance?

If you're an income-seeking investor, a buoyant stock market near its all-time high is actually a problem. At recent prices, the average stock in the benchmark S&P 500 index offers an itty-bitty

Palantir Technologies (NASDAQ: PLTR) is a data analytics company that leverages artificial intelligence (AI) to provide its customers with many opportunities to cut cost and add efficiency to their

The stock market has been choppy in 2025, but overall by the midway point the S&P 500 index was up 5.5%. And it has recently hit a new all-time high, putting into question just how much higher it

Normally, a buy-and-hold strategy pays off, and investors expect to see strong gains from their investments. The S&P 500 (SNPINDEX: ^GSPC) has risen by 200% over the past decade, and mirroring the

One formula to generate strong returns on equity markets involves investing small amounts of money in top stocks regularly over long periods. Buying fractional shares is one way to apply this

When it comes to your hard-earned money, you have a lot of choices about where to spend it. If your physician prescribes a new branded drug, though, you and your insurance company have few options.

Hims & Hers (NYSE: HIMS) and UnitedHealth (NYSE: UNH) suffered huge stock price decreases that attracted investors looking to buy the dip.

*Stock prices used were the afternoon prices of June 28